2014
DOI: 10.4103/0974-7753.138584
|View full text |Cite
|
Sign up to set email alerts
|

Use of low-level laser therapy as monotherapy or concomitant therapy for male and female Androgenetic alopecia

Abstract: Background:Androgenetic alopecia (AGA) is the most common form of hair loss in men and in women. Currently, minoxidil and finasteride are the treatments with the highest levels of medical evidence, but patients who exhibit intolerance or poor response to these treatments are in need of additional treatment modalities.Objective:The aim was to evaluate the efficacy and safety of low-level laser therapy (LLLT) for AGA, either as monotherapy or as concomitant therapy with minoxidil or finasteride, in an office-bas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
7
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 52 publications
(8 citation statements)
references
References 12 publications
1
7
0
Order By: Relevance
“…[ 5 ]” The present study by Munck et al . [ 1 ] at least involved global evaluation which is also a key measurement of the visible changes in hair density and the results closely paralleled the results found in the 4 objective studies.…”
supporting
confidence: 63%
See 3 more Smart Citations
“…[ 5 ]” The present study by Munck et al . [ 1 ] at least involved global evaluation which is also a key measurement of the visible changes in hair density and the results closely paralleled the results found in the 4 objective studies.…”
supporting
confidence: 63%
“…We would like to discuss on the report on “low-level laser therapy for androgenic alopecia. [ 1 ]” Munck et al . have reported that “low-level laser therapy (LLLT) represents a potentially effective treatment for both male and female androgenetic alopecia, either as monotherapy or concomitant therapy.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Eight patients showed significant improvement, 20 patients showed moderate improvement while no improvement was observed in four patients. Improvement was observed in both monotherapy and the dual therapy group [103]. Previously, a Laser comb has been tested in 110 patients with AGA in a double-blind, sham device-controlled, multicenter, and 26-week trial.…”
Section: Androgenetic Alopeciamentioning
confidence: 99%